Sacral neuromodulation (SNM) is a treatment option for selected patients with neurogenic lower urinary tract dysfunction. This sacral neuromodulation treatment for neurogenic bladder uses controlled electrical impulses to modulate communication between the sacral nerves and the bladder.
For patients with persistent urinary urgency, frequency, or urgency incontinence related to neurological conditions, SNM may be considered as part of an individualized treatment plan. Suitability depends on the underlying neurological condition, bladder function, previous treatments, and specialist evaluation.
Patient Assessment and Treatment Eligibility
Neurogenic bladder can result from different neurological disorders, and treatment decisions must reflect the cause and pattern of bladder dysfunction.
SNM treatment for neurogenic bladder may be considered for selected patients with symptoms such as urinary urgency, frequency, and urgency incontinence. A clinical assessment should review the patient's neurological history, urinary symptoms, previous treatments, and relevant diagnostic findings, including urodynamic studies when indicated.
SNM is not appropriate for every patient with neurogenic bladder. The AUA/SUFU guideline advises against offering SNM to patients with neurogenic lower urinary tract dysfunction caused by spinal cord injury or spina bifida. Individual eligibility must therefore be determined by a qualified specialist.
Two-Stage Sacral Neuromodulation Treatment
The two-stage sacral neuromodulation procedure follows two phases.
Stage 1: Trial Stimulation
A temporary stimulation phase is used to assess the patient's response to sacral nerve stimulation. Symptoms are monitored to determine whether the treatment provides meaningful improvement.
The treatment information published on our website uses at least 50% symptom improvement as the threshold for proceeding to permanent implantation.
Stage 2: Permanent Implantation
When the trial produces the required improvement and the specialist confirms suitability, a permanent neurostimulator can be implanted under the skin.
The implanted system is programmable, allowing clinicians to adjust stimulation parameters during follow-up according to the patient's clinical response.
SNM Device Options
Three sacral neuromodulation device options are presented on our website. Their main differences concern battery type, battery life, device weight, and charging requirements.
| Device | Battery Type | Published Battery Life | Weight | Charging |
|---|---|---|---|---|
| PINS G132 | Non-rechargeable | 6–8 years | 25 g | No routine charging |
| PINS G131 | Non-rechargeable | 8–11 years | 35 g | No routine charging |
| PINS G134R | Rechargeable | 20+ years | 36 g | Wireless charging every 2–3 months |
The published device information also lists stimulation parameters of 0–10 V / 0–25 mA and MRI compatibility at 1.5T and 3.0T for all three models. Actual MRI eligibility and operating conditions must be confirmed against the manufacturer's current instructions for the complete implanted system.
The appropriate device depends on the patient's clinical requirements, expected long-term use, and preference for rechargeable or non-rechargeable technology.
International Patient Assessment and Follow-Up
International patients can begin with a remote medical record review before considering travel for treatment.
The assessment process described on our website includes:
- Review of medical records, imaging, urodynamic studies, and previous treatment information.
- Preliminary assessment of potential suitability for SNM.
- Communication support from an English-speaking medical team.
- Coordination of further in-person evaluation in China when required.
After implantation, the website describes remote SNM follow-up and programming support, allowing the clinical team to adjust device settings while patients are back in their home countries. Follow-up and ongoing communication are also included in the international patient service information.
Remote assessment does not replace an in-person diagnosis, and the availability of remote programming depends on the implanted device, technical arrangements, and applicable medical requirements.
Specialist Team and Clinical Support
The medical team information presented on our website is led by Dr. Zhang Yifei, an Associate Chief Physician at the First Affiliated Hospital of Anhui Medical University.
His published professional profile describes more than 30 years of experience in urology, neuro-urology, and urinary control disorders, together with experience in more than 1,000 SNM procedures.
The described care approach includes multidisciplinary assessment involving urology, neuro-urology, and rehabilitation specialists. This is particularly relevant when neurological conditions affect both bladder storage and emptying functions.
Submit Medical Records for an SNM Assessment
If you are considering sacral neuromodulation for neurogenic bladder, submit your existing medical records, imaging, urodynamic results, and previous treatment information for an initial SNM specialist assessment.
The international patient service page describes a written remote assessment within 1–3 business days. The assessment can help clarify whether further specialist evaluation is appropriate.
Remote medical assessments do not replace an in-person diagnosis. SNM eligibility, device selection, treatment decisions, and expected outcomes must be determined by qualified medical professionals based on each patient's condition.
This content is for informational purposes only and does not constitute medical advice.
Hot Tags: sacral neuromodulation for neurogenic bladder, China, price, pricelist, quotation, cost, Congenital Spinal Dysraphism, Ischemic Stroke Cerebrovascular Accident, neurogenic bladder nerve stimulation lead, neurogenic bladder sacral neurostimulator, neurogenic bladder stimulation lead, Vesicoureteral Reflux

